Dr. Erik Wong, Director of Alliance and Externalization, AstraZeneca

Erik Wong received his PhD from Medical Research Council, London, UK. He has spent over 20 years in drug discovery and development, with particular focus on novel agents for psychiatric disorders. He has recruited and led several multi-disciplinary drug discovery teams at Merck Sharp & Dohme Research Laboratory, Roche Bioscience, Pharmacia Pharmaceuticals and Pfizer Inc., leading to late stage clinical development and launches, e.g. MK-801, reboxetine, asenapine, quetiapine. He is the author of over 100 peer-reviewed research publication. From 1998 to 2004, Dr. Wong was an adjunct professor of Psychiatry at Michigan State University. Dr. Wong joined AstraZeneca Pharmaceuticals in 2007. He is currently the Director of Alliance and Externalization for the CNS/Pain Control Research Area, in Wilmington, Delaware, USA. In this role, he is responsible for evaluation and execution of research alliances to identify novel therapeutic approaches for CNS disorders.